Tara Mahon

2.4k total citations
17 papers, 1.2k citations indexed

About

Tara Mahon is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tara Mahon has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Tara Mahon's work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). Tara Mahon is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (6 papers). Tara Mahon collaborates with scholars based in United Kingdom, United States and Ireland. Tara Mahon's co-authors include Luke O'neill, Bent K. Jakobsen, Nicole J. Horwood, Brian M. J. Foxwell, Fionula M. Brennan, David Webster, John McDaid, Jamie I. D. Campbell, Steven M. Dunn and Brian Cameron and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Tara Mahon

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Mahon United Kingdom 11 811 561 308 163 152 17 1.2k
Jacki Kornbluth United States 21 763 0.9× 285 0.5× 371 1.2× 80 0.5× 130 0.9× 53 1.3k
S Visonneau United States 19 412 0.5× 341 0.6× 222 0.7× 128 0.8× 87 0.6× 35 999
W J Leonard United States 12 830 1.0× 386 0.7× 298 1.0× 68 0.4× 92 0.6× 15 1.2k
Harry Segall Israel 10 391 0.5× 259 0.5× 695 2.3× 129 0.8× 43 0.3× 19 1.1k
Shigeki Takemoto Japan 17 1.2k 1.5× 363 0.6× 347 1.1× 46 0.3× 60 0.4× 49 1.6k
An M. T. Van Nuffel Belgium 18 851 1.0× 597 1.1× 697 2.3× 179 1.1× 28 0.2× 26 1.3k
Alpha Peled Israel 16 291 0.4× 241 0.4× 286 0.9× 106 0.7× 82 0.5× 50 875
Etsuko Ishizaka-Ikeda Japan 7 630 0.8× 502 0.9× 335 1.1× 308 1.9× 72 0.5× 7 1.2k
Jennifer N. Durham United States 18 400 0.5× 649 1.2× 379 1.2× 139 0.9× 40 0.3× 53 1.2k
Krzysztof Grzegorzewski United States 15 370 0.5× 214 0.4× 312 1.0× 49 0.3× 88 0.6× 34 862

Countries citing papers authored by Tara Mahon

Since Specialization
Citations

This map shows the geographic impact of Tara Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Mahon more than expected).

Fields of papers citing papers by Tara Mahon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Mahon. The network helps show where Tara Mahon may publish in the future.

Co-authorship network of co-authors of Tara Mahon

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Mahon. A scholar is included among the top collaborators of Tara Mahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Mahon. Tara Mahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Newey, Alice, Guillaume Rieunier, Tara Mahon, et al.. (2025). Cell-targeted PD-1 agonists are potent NK-cell inhibitors. Frontiers in Immunology. 16. 1640509–1640509.
2.
Collins, Laura C., Ricardo J. Carreira, Adel Benlahrech, et al.. (2024). High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer–testis antigen PRAME. PubMed. 4(1). ltae008–ltae008. 2 indexed citations
3.
Heller, Martin, Amelia Willits‐Smith, Tara Mahon, Gregory A. Keoleian, & Donald Rose. (2021). Individual US diets show wide variation in water scarcity footprints. Nature Food. 2(4). 255–263. 32 indexed citations
4.
Bossi, Giovanna, Adam P. Curnock, Peter Weber, et al.. (2021). 58-LB: ß-Cell Targeted Immune Suppressive PD-1 Bispecific Agonists: A Novel Approach to Treat Type 1 Diabetes. Diabetes. 70(Supplement_1).
5.
Yang, Hongbing, Sandrine Buisson, Giovanna Bossi, et al.. (2016). Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors. Molecular Therapy. 24(11). 1913–1925. 31 indexed citations
6.
Rizkallah, P.J., Ruth Simmons, Joseph Dukes, et al.. (2016). Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. Scientific Reports. 6(1). 18851–18851. 77 indexed citations
7.
Bossi, Giovanna, Jane Harper, Joseph Dukes, et al.. (2015). ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
8.
Hassan, Namir J., Giovanna Bossi, Katherine J. Adams, et al.. (2014). Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma. Cancer Research. 74(19_Supplement). 2900–2900. 1 indexed citations
9.
Robbins, Paul F., Yong F. Li, Mona El‐Gamil, et al.. (2008). Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions. The Journal of Immunology. 180(9). 6116–6131. 252 indexed citations
10.
Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations
11.
Horwood, Nicole J., Theresa H. Page, John McDaid, et al.. (2006). Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production. The Journal of Immunology. 176(6). 3635–3641. 179 indexed citations
12.
Purbhoo, Marco A., Deborah H. Sutton, Joanna E. Brewer, et al.. (2006). Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. The Journal of Immunology. 176(12). 7308–7316. 74 indexed citations
13.
Dunn, Steven M., P.J. Rizkallah, Emma Baston, et al.. (2006). Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivity. Protein Science. 15(4). 710–721. 86 indexed citations
14.
Horwood, Nicole J., Tara Mahon, John McDaid, et al.. (2003). Bruton's Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor α Production. The Journal of Experimental Medicine. 197(12). 1603–1611. 131 indexed citations
15.
Mahon, Tara & Luke O'neill. (1995). Studies into the Effect of the Tyrosine Kinase Inhibitor Herbimycin A on NF-κB Activation in T Lymphocytes EVIDENCE FOR COVALENT MODIFICATION OF THE p50 SUBUNIT. Journal of Biological Chemistry. 270(48). 28557–28564. 105 indexed citations
16.
Stapleton, Philip P., Tara Mahon, Peter Nowlan, & F. J. Bloomfield. (1994). Effects of In-vivo Administration of Taurine and HEPES on the Inflammatory Response in Rats. Journal of Pharmacy and Pharmacology. 46(9). 745–750. 16 indexed citations
17.
Mahon, Tara, Paul Brennan, & Luke O'neill. (1993). Evidence for a redox-sensitive protein tyrosine kinase in nuclear factor kappa B activation and interleukin 2 production in EL4.NOB1 cells. Biochemical Society Transactions. 21(4). 389S–389S. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacki Kornbluth Breakdown of academic impact, for papers by S Visonneau Breakdown of academic impact, for papers by W J Leonard Breakdown of academic impact, for papers by Harry Segall Breakdown of academic impact, for papers by Shigeki Takemoto Breakdown of academic impact, for papers by An M. T. Van Nuffel Breakdown of academic impact, for papers by Alpha Peled Breakdown of academic impact, for papers by Etsuko Ishizaka-Ikeda Breakdown of academic impact, for papers by Jennifer N. Durham Breakdown of academic impact, for papers by Krzysztof Grzegorzewski
Rankless by CCL
2026